Rashieda Gluck
Directeur Technique/Scientifique/R&D chez DIANTHUS THERAPEUTICS, INC.
Postes actifs de Rashieda Gluck
Sociétés | Poste | Début | Fin |
---|---|---|---|
DIANTHUS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 11/09/2023 | - |
Historique de carrière de Rashieda Gluck
Anciens postes connus de Rashieda Gluck
Sociétés | Poste | Début | Fin |
---|---|---|---|
AURINIA PHARMACEUTICALS INC. | Directeur Technique/Scientifique/R&D | 01/05/2014 | 01/04/2022 |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Directeur Technique/Scientifique/R&D | 01/12/2013 | 01/06/2015 |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Directeur Technique/Scientifique/R&D | 01/01/2008 | 01/07/2013 |
KANE BIOTECH INC. | Directeur/Membre du Conseil | 22/05/2018 | - |
Independent Dir/Board Member | 22/05/2018 | - | |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Directeur Technique/Scientifique/R&D | - | - |
Formation de Rashieda Gluck
University of British Columbia | Undergraduate Degree |
Statistiques
Internationale
Canada | 6 |
Suisse | 2 |
Etats-Unis | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 5 |
Undergraduate Degree | 1 |
Director/Board Member | 1 |
Sectorielle
Health Technology | 6 |
Commercial Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
KANE BIOTECH INC. | Commercial Services |
AURINIA PHARMACEUTICALS INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Aspreva Pharmaceuticals Corp. manufactured pharmaceutical products. It offered therapeutic products, research equipment, and related services. The firm developed drugs for the treatment of cancer, infectious diseases, and immune disorders. The company was founded in 2001 and is headquartered in Victoria, Canada. | Health Technology |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada. | Health Technology |
- Bourse
- Insiders
- Rashieda Gluck
- Expérience